KwanDong University   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Gangneung Korea, Republic of (1954)

Organization Overview

First Clinical Trial
2008
NCT00633581
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Kwandong University College of Medicine Cheil Hospital | Kwandong University College of Medicine & Myongji Hospital | Kwandong university medical school Cheil hospital | Kwandong University Myongji Hospital | KwanDong University Myungji Hospital

Active Ingredients

Drugs in Phase 3 Trials (2)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

vitamin c (1 trial)

Drugs in Phase 2 Trials (3)

bls_ilb_710c (1 trial)

bls_ils_e710c (1 trial)

l-glutamic acid (1 trial)

Drugs in Other Trials (1)

rivastigmine (exelon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma in Situ (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 2)

Fatigue (Phase 3)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 6